GLAUKOS Corp Share-based Payment Arrangement, Expense
GLAUKOS Corp (GKOS) reported Share-based Payment Arrangement, Expense of $28.86 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-07-29
- GLAUKOS Corp share-based payment arrangement, expense for the quarter ending 2026-06-30 was $28.86M, a 60.19% increase year-over-year.
- GLAUKOS Corp share-based payment arrangement, expense for the quarter ending 2026-03-31 was $19.14M, a 47.42% increase year-over-year.
- GLAUKOS Corp share-based payment arrangement, expense for the quarter ending 2025-12-31 was $17.30M, a 29.99% increase year-over-year.
- GLAUKOS Corp share-based payment arrangement, expense for the quarter ending 2025-09-30 was $14.91M, a 3.42% increase year-over-year.
- GLAUKOS Corp share-based payment arrangement, expense for fiscal 2025 was $63.22M, a 25.91% increase from fiscal 2024.
- GLAUKOS Corp share-based payment arrangement, expense for fiscal 2024 was $50.21M, a 15.34% increase from fiscal 2023.
- GLAUKOS Corp share-based payment arrangement, expense for fiscal 2023 was $43.53M, a 12.88% increase from fiscal 2022.
- GLAUKOS Corp share-based payment arrangement, expense for fiscal 2022 was $38.56M, a 27.91% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.86M 10-Q · filed 2026-07-29 | $48.01M 10-Q · filed 2026-07-29 | $65.31M derived: sum of 3 quarters · filed 2026-07-29 | $80.22M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $19.14M 10-Q · filed 2026-04-30 | $36.44M derived: sum of 2 quarters · filed 2026-04-30 | $51.36M derived: sum of 3 quarters · filed 2026-04-30 | $69.38M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $17.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $32.21M derived: sum of 2 quarters · filed 2026-02-23 | $50.23M derived: sum of 3 quarters · filed 2026-07-29 | $63.22M 10-K · filed 2026-02-23 |
| 2025-09-30 | $14.91M 10-Q · filed 2025-10-31 | $32.93M derived: sum of 2 quarters · filed 2026-07-29 | $45.92M 10-Q · filed 2025-10-31 | $59.23M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $18.02M 10-Q · filed 2026-07-29 | $31.00M 10-Q · filed 2026-07-29 | $44.31M derived: sum of 3 quarters · filed 2026-07-29 | $58.73M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $12.99M 10-Q · filed 2026-04-30 | $26.30M derived: sum of 2 quarters · filed 2026-04-30 | $40.72M derived: sum of 3 quarters · filed 2026-04-30 | $52.03M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $13.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $27.73M derived: sum of 2 quarters · filed 2026-02-23 | $39.04M derived: sum of 3 quarters · filed 2026-02-23 | $50.21M 10-K · filed 2026-02-23 |
| 2024-09-30 | $14.42M 10-Q · filed 2025-10-31 | $25.73M derived: sum of 2 quarters · filed 2025-10-31 | $36.90M 10-Q · filed 2025-10-31 | $49.88M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $11.31M 10-Q · filed 2025-08-04 | $22.48M 10-Q · filed 2025-08-04 | $35.47M derived: sum of 3 quarters · filed 2026-02-23 | $45.95M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $11.16M 10-Q · filed 2025-05-01 | $24.15M derived: sum of 2 quarters · filed 2026-02-23 | $34.64M derived: sum of 3 quarters · filed 2026-02-23 | $44.51M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $23.47M derived: sum of 2 quarters · filed 2026-02-23 | $33.34M derived: sum of 3 quarters · filed 2026-02-23 | $43.53M 10-K · filed 2026-02-23 |
| 2023-09-30 | $10.48M 10-Q · filed 2024-11-05 | $20.36M derived: sum of 2 quarters · filed 2024-11-05 | $30.54M 10-Q · filed 2024-11-05 | $42.23M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $9.87M 10-Q · filed 2024-08-02 | $20.06M 10-Q · filed 2024-08-02 | $31.75M derived: sum of 3 quarters · filed 2025-02-25 | $41.16M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $10.18M 10-Q · filed 2024-05-03 | $21.87M derived: sum of 2 quarters · filed 2025-02-25 | $31.28M derived: sum of 3 quarters · filed 2025-02-25 | $41.82M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $11.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $21.10M derived: sum of 2 quarters · filed 2025-02-25 | $31.64M derived: sum of 3 quarters · filed 2025-02-25 | $38.56M 10-K · filed 2025-02-25 |
| 2022-09-30 | $9.41M 10-Q · filed 2023-11-01 | $19.95M derived: sum of 2 quarters · filed 2023-11-01 | $26.87M 10-Q · filed 2023-11-01 | $34.10M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $10.54M 10-Q · filed 2023-08-02 | $17.46M 10-Q · filed 2023-08-02 | $24.69M derived: sum of 3 quarters · filed 2024-02-23 | $30.88M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $6.92M 10-Q · filed 2023-05-04 | $14.15M derived: sum of 2 quarters · filed 2024-02-23 | $20.34M derived: sum of 3 quarters · filed 2024-02-23 | $28.32M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $7.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $13.41M derived: sum of 2 quarters · filed 2024-02-23 | $21.40M derived: sum of 3 quarters · filed 2024-02-23 | $30.15M 10-K · filed 2024-02-23 |
| 2021-09-30 | $6.19M 10-Q · filed 2022-11-04 | $14.17M derived: sum of 2 quarters · filed 2022-11-04 | $22.92M 10-Q · filed 2022-11-04 | $31.66M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $7.98M 10-Q · filed 2022-08-05 | $16.73M 10-Q · filed 2022-08-05 | $25.48M derived: sum of 3 quarters · filed 2023-02-24 | $35.13M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $8.75M 10-Q · filed 2022-05-05 | $17.49M derived: sum of 2 quarters · filed 2023-02-24 | $27.15M derived: sum of 3 quarters · filed 2023-02-24 | $38.05M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $18.40M derived: sum of 2 quarters · filed 2023-02-24 | $29.30M derived: sum of 3 quarters · filed 2023-02-24 | $43.30M 10-K · filed 2023-02-24 |
| 2020-09-30 | $9.66M 10-Q · filed 2021-11-08 | $20.56M derived: sum of 2 quarters · filed 2021-11-08 | $34.56M 10-Q · filed 2021-11-08 | $50.12M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $10.90M 10-Q · filed 2021-08-05 | $24.90M 10-Q · filed 2021-08-05 | $40.46M derived: sum of 3 quarters · filed 2022-02-28 | $49.01M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $14.01M 10-Q · filed 2021-05-06 | $29.56M derived: sum of 2 quarters · filed 2022-02-28 | $38.11M derived: sum of 3 quarters · filed 2022-02-28 | $46.36M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $15.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $24.11M derived: sum of 2 quarters · filed 2022-02-28 | $32.35M derived: sum of 3 quarters · filed 2022-02-28 | $39.48M 10-K · filed 2022-02-28 |
| 2019-09-30 | $8.55M 10-Q · filed 2020-11-05 | $16.79M derived: sum of 2 quarters · filed 2020-11-05 | $23.92M 10-Q · filed 2020-11-05 | $30.59M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $8.25M 10-Q · filed 2020-08-07 | $15.38M 10-Q · filed 2020-08-07 | $22.04M derived: sum of 3 quarters · filed 2021-03-01 | $29.22M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $7.13M 10-Q · filed 2020-05-07 | $13.80M derived: sum of 2 quarters · filed 2021-03-01 | $20.97M derived: sum of 3 quarters · filed 2021-03-01 | $27.43M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $13.84M derived: sum of 2 quarters · filed 2021-03-01 | $20.30M derived: sum of 3 quarters · filed 2021-03-01 | $25.70M 10-K · filed 2021-03-01 |
| 2018-09-30 | $7.17M 10-Q · filed 2019-11-06 | $13.63M derived: sum of 2 quarters · filed 2019-11-06 | $19.04M 10-Q · filed 2019-11-06 | $23.98M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $6.46M 10-Q · filed 2019-08-08 | $11.86M 10-Q · filed 2019-08-08 | $16.80M derived: sum of 3 quarters · filed 2020-03-02 | $21.52M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $5.40M 10-Q · filed 2019-05-08 | $10.34M derived: sum of 2 quarters · filed 2020-03-02 | $15.06M derived: sum of 3 quarters · filed 2020-03-02 | $19.79M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $9.66M derived: sum of 2 quarters · filed 2020-03-02 | $14.39M derived: sum of 3 quarters · filed 2020-03-02 | $17.59M 10-K · filed 2020-03-02 |
| 2017-09-30 | $4.72M 10-Q · filed 2018-11-07 | $9.45M derived: sum of 2 quarters · filed 2018-11-07 | $12.65M 10-Q · filed 2018-11-07 | $15.32M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $4.73M 10-Q · filed 2018-08-06 | $7.93M 10-Q · filed 2018-08-06 | $10.61M derived: sum of 3 quarters · filed 2019-02-28 | $13.26M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $3.20M 10-Q · filed 2018-05-09 | $5.87M derived: sum of 2 quarters · filed 2019-02-28 | $8.52M derived: sum of 3 quarters · filed 2019-02-28 | $10.57M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $5.32M derived: sum of 2 quarters · filed 2019-02-28 | $7.37M derived: sum of 3 quarters · filed 2019-02-28 | $8.79M 10-K · filed 2019-02-28 |
| 2016-09-30 | $2.65M 10-Q · filed 2017-11-08 | $4.70M derived: sum of 2 quarters · filed 2017-11-08 | $6.12M 10-Q · filed 2017-11-08 | $7.67M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $2.05M 10-Q · filed 2017-08-07 | $3.46M 10-Q · filed 2017-08-07 | $5.02M derived: sum of 3 quarters · filed 2018-02-28 | $6.58M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $1.42M 10-Q · filed 2017-05-04 | $2.98M derived: sum of 2 quarters · filed 2018-02-28 | $4.53M derived: sum of 3 quarters · filed 2018-02-28 | $8.93M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $3.11M derived: sum of 2 quarters · filed 2018-02-28 | $7.52M derived: sum of 3 quarters · filed 2018-02-28 | $7.89M 10-K · filed 2018-02-28 |
| 2015-09-30 | $1.55M 10-Q · filed 2016-11-14 | $5.96M derived: sum of 2 quarters · filed 2016-11-14 | $6.33M 10-Q · filed 2016-11-14 | $6.71M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $4.41M 10-Q · filed 2016-08-04 | $4.78M 10-Q · filed 2016-08-04 | $5.16M derived: sum of 3 quarters · filed 2017-03-15 | $5.55M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $353.00K 10-Q · filed 2016-05-04 | $753.00K derived: sum of 2 quarters · filed 2017-03-15 | $1.15M derived: sum of 3 quarters · filed 2017-03-15 | $1.51M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $792.00K derived: sum of 2 quarters · filed 2017-03-15 | $1.16M derived: sum of 3 quarters · filed 2017-03-15 | $1.53M 10-K · filed 2017-03-15 |
| 2014-09-30 | $392.00K 10-Q · filed 2015-11-12 | $756.00K derived: sum of 2 quarters · filed 2015-11-12 | $1.13M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $364.00K 10-Q · filed 2015-08-13 | $738.00K 10-Q · filed 2015-08-13 | ||
| 2013-12-31 | $1.35M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |